Search - tctmd.com

Displaying 21 - 27 of 27

Sort: Relevancy | Date

Presentation THT Abstracts 2025

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Presenter: Kanika Mody

February 11, 2025

Presentation THT Abstracts 2025

Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc

Presenter: John DePietro

February 11, 2025

Presentation THT Abstracts 2025

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Presenter: Van-Khue Ton

February 11, 2025

Presentation THT 2025

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

Presenter: Boaz Elad

February 11, 2025

Presentation THT 2025

Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc

Presenter: John DePietro

February 11, 2025

News Daily News

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Todd Neale

January 23, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

Advertisement

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content